Hyperhomocysteinemia and coronary artery disease in Pakistan

Journal of the Pakistan Medical Association

Volumn 56, Issue 6, 2006, Pages 282-284

  Iqbal, M Perwaiz ^a  

^a AGA KHAN UNIVERSITY HOSPITAL   (Pakistan)

Author keywords

[No Author keywords available]

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE; PYRIDOXINE;

ACUTE HEART INFARCTION; ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; GENE MUTATION; HUMAN; HYPERHOMOCYSTEINEMIA; PAKISTAN; PREVALENCE; REVIEW; RISK FACTOR; SOCIAL CLASS; VITAMIN DEFICIENCY; CORONARY ARTERY ATHEROSCLEROSIS; MALE;

CORONARY ARTERIOSCLEROSIS; HUMANS; HYPERHOMOCYSTEINEMIA; MALE; PAKISTAN;

EID: 34248666990     PISSN: 00309982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (34)

1. Nishtar S. Prevention of coronary heart disease in South Asia. Lancet 2002;360:1015-8.
2. Samad A. Coronary artery disease in Pakistan: preventive aspects. Pakistan J Cardiol 2003;14:59-60.
3. Balarajan R. Ethnic differences in mortality from ischaemic heart disease and cerebrovascular disease in England and Wales. BMJ 1991;302:560-4.
4. Saleheen D, Frossard P. CAD risk factors and acute myocardial infarction in Pakistan. Acta Cardiol 2004;59:417-24.
5. Siddiqui S, Ijaz B, Khan AA. Coronary risk profile study. Pak J Med Res 1992;31:94-100.
6. Virk Z, Khan AA, Bokhari AM. Ischemic heart disease in young population (35 years). A clinical profile. Pakistan J Cardiol 1995;6:64-6.
7. Samad A, Sahibzada WA, Nazir F, Khan AA, Mattu A, Memon N, et al. Incidence of acute myocardial infarction. Pakistan J Cardiol 1996;7:13-7.
8. Welch GN, Loscalzo J. Homocysteine and atherothrombosis. N Engl J Med 1998;338:1042-50.
9. Eikelboom JW, Lonn E, Genest Jr J, Hankey G, Yusuf S. Homocyst(e)ine and cardiovascular disease: a critical review of the epidemiologic evidence. Ann Intern Med 1999;131:363-75.
10. Ueland PM, Refsum H, Stabler SP, Malinow MR, Andersson A, Allen RH. Total homocysteine in plasma or serum: methods and clinical applications. Clin Chem 1993;39:1764-79.
11. Refsum H. Homocysteine in clinical practice. In: Homocysteine Day 2002, Bolander-Gouaille C (ed), Sweden: Abbott Scandinavia, 2002, pp 17-19.
12. Robinson K, Mayer EL, Miller DP, Green R, van Lente F, Gupta A et al. Hyperhomocysteinemia and low pyridoxal phosphate. Common and independent reversible risk factors for coronary artery disease. Circulation 1995;92:2825-30.
13. Jacobsen DW. Homocysteine and vitamins in cardiovascular disease. Clin Chem 1998;44:1833-43.
14. Mansoor MA, Ueland PM, Aarsland A, Svardal AM. Redox status and protein binding of plasma homocysteine and other aminothiols in patients with homocystinuria. Metabolism1993;42:1481-5.
15. Bostom AG, Lathrop L. Hyperhomocysteinemia in end-stage renal disease: prevalence, etiology, and potential relationship to arteriosclerotic outcomes. Kidney Int 1997;52:10-20.
16. Knekt P, Reunanen A, Alfthan G, Heliövaara M, Rissanen H, Marniemi J, et al. Hyperhomocystinemia: a risk factor or a consequence of coronary heart disease? Arch Intern Med 2001;161:1589-94.
17. Mangoni AA, Jackson SH. Homocysteine and cardiovascular disease: current evidence and future prospects. Am J Med 2002;112:556-65.
18. Nygard O, Vollset SE, Refsum H, Stensvold I, Tverdal A, Nordrehaug JE, et al. Total plasma homocysteine and cardiovascular risk profile. The Hordaland Homocysteine Study. JAMA 1995;274:1526-33.
19. Wald DS, Law M, Morris JK. Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis. BMJ 2002;325:1202-6.
20. Aamir M, Sattar A, Dawood MM, Dilawar M, Ijaz A, Anwar M. Hyperhomocysteinemia as a risk factor for ischemic heart disease. J Coll Physician Surg Pak 2004;14:518-21.
21. Iqbal MP, Ishaq M, Kazmi KA, Yousuf FA, Mehboobali N, Ali SA et al. Role of vitamins B6, B12 and folic acid on hyperhomocysteinemia in a Pakistani population of patients with acute myocardial infarction. Nutr Metab Cardiovas Dis 2005;15:100-8.
22. Selhub J, Jacques PF, Wilson PW, Rush D, Rosenberg IH. Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. JAMA 1993;270:2693-8.
23. Sastry BK, Indira N, Anand B, Kedarnath Prabha BS, Raju BS. A case-control study of plasma homocysteine levels in South Indians with and without coronary artery disease. Indian Heart J 2001;53:749-53.
24. Leowattana W, Mahanonda N, Bhuripunyo K, Pokum S. Association between serum homocysteine, vitamin B12 and folate and Thai coronary artery disease patients. J Med Assoc Thai 2000; 83;536-42.
25. Tokgozoglu SL, Alikasifoglu M, Unsal, Atalar E, Aytemir K, Ozer N, et al. Methylene- tetrahydrofolate reductase genotype and the risk and extent of coronary artery disease in a population with low plasma folate. Heart 1999; 81:518-22.
26. Herrmann W, Obeid R, Jouma M. Hyperhomocysteinemia and vitamin B-12 deficiency are more striking in Syrians than in Germans - causes and implications. Atherosclerosis 2003;166:143-50.
27. Iqbal MP, Fatima T, Parveen S, Yousuf FA, Shafiq M, Mehboobali N, et al. Lack of association of methylenetetrahydrofolate reductase 677C>T mutation with coronary artery disease in Pakistani population. J Mol Genet Med 2005;1:26-32.
28. Iqbal MP, Frossard PM. Methylenetetrahydrofolate reductase gene and coronary artery disease. J Pak Med Assoc 2003;53:33-6.
29. Zafar F, Idress MM, Ahmed Z. Prevalence of enteric infections in suburban Karachi: A study focused on Landhi-Korangi area. International Nutrition Conference-2004. Nutritionists Association of Pakistan, Lahore, pp.157 (abstract).
30. Ismail J, Jafar TH, Jafary FH, White F, Faruqui AM, Chaturvedi N. Risk factors for non-fatal myocardial infarction in young South Asian adults. Heart 2004; 90: 259-63.
31. Iqbal MP, Shafiq M, Mehboobali N, Iqbal SP, Abbasi K. Variability in lipid profile in Pakistani patients with acute myocardial infarction. J Pak Med Assoc 2004; 54:544-9.
32. Iqbal MP, Shafiq M, Mehboobali N, Iqbal SP, Abbasi K, Azam I, et al. Hypertriglyceridemia and low HDL-cholesterol are the major lipid abnormalities in normal Pakistani adults: are these contributing to the high rates of coronary artery disease in this population? Pak J Med Sci 2004;20:385-91.
33. Iqbal SP, Dodani S, Qureshi R. Risk factors and behaviours for coronary artery disease (CAD) among ambulatory Pakistanis. J Pak Med Assoc 2004;54:261-5.
34. Nishtar S, Wierzbicki AS, Lumb PJ, Lambert-Hammill M, Turner CN, Crook MA, et al. Waist-hip ratio and low-HDL predict the risk of coronary artery disease in Pakistanis. Curr Med Res Opin 2004;20:55-62.